GLUCOCORTICOID AND ESTROGEN-RECEPTORS HAVE ELEVATED ACTIVITY IN HUMANENDOMETRIAL AND OVARIAN-TUMORS AS COMPARED TO THE ADJACENT NORMAL-TISSUES AND RECOGNIZE SEQUENCE ELEMENTS OF THE H-RAS PROTOONCOGENE
G. Zachos et al., GLUCOCORTICOID AND ESTROGEN-RECEPTORS HAVE ELEVATED ACTIVITY IN HUMANENDOMETRIAL AND OVARIAN-TUMORS AS COMPARED TO THE ADJACENT NORMAL-TISSUES AND RECOGNIZE SEQUENCE ELEMENTS OF THE H-RAS PROTOONCOGENE, Japanese journal of cancer research, 87(9), 1996, pp. 916-922
We examined the level of receptor binding in H-ras elements, using nuc
lear extracts derived from human endometrial and ovarian lesions and f
rom adjacent normal tissue in gel retardation assays. We found increas
ed binding of the glucocorticoid receptor (GR) to the H-ras GR element
In more than 90% of endometrial tumors and in all ovarian tumors test
ed, as compared to the corresponding adjacent normal tissue. Additiona
lly, we found elevated binding of the estrogen receptor (ER) in H-ras
ER element in all pairs of ovarian tumor/normal tissue tested, whereas
in ER-negative control breast tumor/normal tissue pairs, no differenc
es in ER DNA-binding levels were observed. These results suggest that
steroid hormone receptor binding could directly activate the H-ras onc
ogenic potency in human endometrial and ovarian lesions, providing add
itional evidence for the role of H-ras expression in hormonally respon
sive human cancers.